Willow Biosciences Inc Capital Reinvestment Ratio

Latest as of March 2019: 1.45x

Willow Biosciences Inc capital reinvestment ratio. Willow Biosciences Inc (WLLW) has a Capital Reinvestment Ratio of 1.45x as of March 2019, meaning it reinvests 1% of its operating cash flow (CA$10.14K) in capital expenditures (CA$14.67K). See WLLW cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.45x

Capex / Operating Cash Flow

Operating Cash Flow

CA$10.14K

CAD

Capital Expenditures

CA$14.67K

CAD

Data as of

Mar 2019

Most recent filing

Willow Biosciences Inc Capital Reinvestment Ratio by Year (None–None)

Willow Biosciences Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see WLLW operating cash flow.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow